These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 9294330)

  • 1. [Removal ability of immunoglobulins in plasma exchange and double-filtration plasmapheresis].
    Tagawa Y; Yuki N
    Rinsho Shinkeigaku; 1997 May; 37(5):410-2. PubMed ID: 9294330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ability to remove immunoglobulins and antiganglioside antibodies by double filtration plasmapheresis in Guillain-Barré syndrome: is it equivalent to plasma exchange?
    Tagawa Y; Yuki N; Hirata K
    Ther Apher; 1997 Nov; 1(4):336-9. PubMed ID: 10225726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tryptophan-immobilized column-based immunoadsorption as the choice method for plasmapheresis in Guillain-Barré syndrome.
    Okamiya S; Ogino M; Ogino Y; Irie S; Kanazawa N; Saito T; Sakai F
    Ther Apher Dial; 2004 Jun; 8(3):248-53. PubMed ID: 15154879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of anti-glycolipid antibody-associated neuropathy].
    Yuki N
    Rinsho Shinkeigaku; 1999 Dec; 39(12):1232-4. PubMed ID: 10791085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasmapheresis in 2 children with Guillain-Barré syndrome].
    Rotteveel JJ; Mullaart RA; Weemaes CM; van Empelen R
    Tijdschr Kindergeneeskd; 1983 Apr; 51(2):57-62. PubMed ID: 6879585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ability to remove immunoglobulins and anti-ganglioside antibodies by plasma exchange, double-filtration plasmapheresis and immunoadsorption.
    Tagawa Y; Yuki N; Hirata K
    J Neurol Sci; 1998 Apr; 157(1):90-5. PubMed ID: 9600682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Apheresis therapy in Guillain-Barré syndrome].
    Nagayama H; Katayama Y
    Nihon Rinsho; 2008 Jun; 66(6):1195-9. PubMed ID: 18540370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of the efficacy of plasma exchange, immunoadsorption plasmapheresis and corticosteroid administration in the treatment of Guillain-Barré syndrome].
    Yamazaki M; Koh CS; Hanyu N; Sakai T; Inoue A; Yanagisawa N
    Arerugi; 1995 Apr; 44(4):498-502. PubMed ID: 7598643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Double filtration and immunoadsorption plasmapheresis in Guillain-Barré syndrome].
    Kuwabara S; Nakajima M; Moroo I; Hirayama K
    Rinsho Shinkeigaku; 1996 Feb; 36(2):289-92. PubMed ID: 8752682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma exchange versus double filtration plasmapheresis in the treatment of Guillain-Barré syndrome.
    Lyu RK; Chen WH; Hsieh ST
    Ther Apher; 2002 Apr; 6(2):163-6. PubMed ID: 11982959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of Guillain-Barré syndrome with high-dose intravenous immunoglobulins--a comparison with plasma exchange].
    Kamei T; Nakagawa H; Uchiyama F; Fukuyama J
    Rinsho Shinkeigaku; 1993 Jun; 33(6):660-2. PubMed ID: 8403689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of intravenous immunoglobulins. A case of Guillain-Barré syndrome].
    Hidou M; Olivier J; Vivant JF
    Rev Neurol (Paris); 1992; 148(11):706-8. PubMed ID: 1303562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma exchange and i.v.-immunoglobulins: new approaches to the treatment of Guillain-Barre' syndrome.
    Fasanaro AM; Pizza V; Stella L
    Acta Neurol (Napoli); 1992; 14(4-6):369-80. PubMed ID: 1293980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of immunoglobulin M reduction via therapeutic dose of simple plasma exchange and double filtration plasmapheresis using membrane separation in patients with hyperviscosity syndrome caused by Waldenstrom macroglobulinemia.
    Miyamoto Y; Hamasaki Y; Matsumoto A; Doi K; Noiri E; Nangaku M
    J Clin Apher; 2018 Oct; 33(5):611-615. PubMed ID: 30188580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Double filtration plasmapheresis (DFPP) in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)].
    Kumazawa K; Yuasa N; Mitsuma T; Nagamatsu M; Sobue G
    Rinsho Shinkeigaku; 1998 Aug; 38(8):719-23. PubMed ID: 9916516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The number of plasma exchanges in Guillain-Barré syndrome: evaluation by the removal rate of immunoglobulin G].
    Tagawa Y; Yuki N; Hirata K
    Rinsho Shinkeigaku; 1998; 38(10-11):951-4. PubMed ID: 10203982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A controlled study of double filtration plasmapheresis in the treatment of active rheumatoid arthritis.
    Yu X; Ma J; Tian J; Jiang S; Xu P; Han H; Wang L
    J Clin Rheumatol; 2007 Aug; 13(4):193-8. PubMed ID: 17762452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of post-transplant double filtration plasmapheresis on recurrent focal and segmental glomerulosclerosis in renal transplant recipients.
    Otsubo S; Tanabe K; Shinmura H; Ishikawa N; Tokumoto T; Hattori M; Ito K; Nitta K; Akiba T; Nihei H; Toma H
    Ther Apher Dial; 2004 Aug; 8(4):299-304. PubMed ID: 15274681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Status of plasmapheresis for the treatment of toxic epidermal necrolysis in Japan.
    Yamada H; Takamori K
    Ther Apher Dial; 2008 Oct; 12(5):355-9. PubMed ID: 18937717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmapheresis in the treatment of four cases of Guillain-Barré syndrome (acute form).
    Zerbi D; Celano I; Forlani G; Garelli S; Mosconi L; Valbonesi M
    Ital J Neurol Sci; 1981 Dec; 2(4):331-6. PubMed ID: 7333823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.